Dr. Jennifer Jones-McMeans is a Divisional Vice President of Global Clinical Affairs at Abbott Vascular Business and she sheds light on the FDA guidance to encourage sponsors of clinical trials to include all genders, ethnicities, and under-represented patients to participate. New guidelines are more organized and provide better guidance for what sponsors of clinical trials should consider during their submissions to the FDA.

“In this episode, we learn about CISCRP’s AWARE for All campaign, which builds awareness of, creates access to and encourages participation in clinical trials. Ellyn Getz, Associate Director of Development and Community Engagement at CISCRP, The Center for Information and Study on Clinical Research Participation, discusses AWARE for All.”

“In this episode we will talk about diversity in Hepatitis B clinical trials with Dr. Chari Cohen and Dr. Yasmin Ibrahim from the Hepatitis B Foundation.”

“In this episode, we’ll be talking about participation in lupus clinical trials and the importance of diversity in lupus clinical trials with RADM Felicia Collins, Director of the Office of Minority Health in the Department of Health and Human Services.”

“In this episode, Dr. Brownsyne Tucker Edmonds and Dr. Sylk Sotto talk with Dr. Aaron Carroll about the importance of diversity and equity in research, higher education, and medicine. They share insights about underlying issues they’ve seen and talk about ways to encourage success for underrepresented minorities.”

“Clinical trials are vital in understanding whether a medicine in development is safe and effective.”

“Leaders across our company explain how we’re addressing diversity in clinical trials and across our clinical research program.”

“In this series, we answer:
- How does diversity in clinical trials impact the development of new medicines?
- How can researchers tell if therapies will work for patients of different racial or ethnic backgrounds?”

“As of June 23, 2020, the coronavirus has taken the lives of over 120,000 Americans. Black people are continuing to face the highest rates of mortality from the virus at one in every 1,500 compared to White counterparts at one in every 3,600. The stark contrast in mortality rates exposes a long history of health disparities in the Black community that have been amplified due to the ease in which COVID 19 is contracted. While is it imperative to follow the safety guidelines presented by organizations like the Center for Disease Control and the World Health Organization to slow the spread of the virus, it is also important that Black people are enrolling in clinical trials to find a vaccine for the virus. As our community is one of the most affected by COVID 19, participation in clinical trials is necessary for researchers to find a cure that will work for us. This panel will address the historic mistrust between Black people and the medical community and examples of the medical community trying to right the wrongs of the past. Speakers will also share how HBCUs and other trusted Black organizations are working with the medical community to create safe and trusted pathways to facilitate clinical trials for the Black community. Sponsored by Eli Lilly, Biogen, Genetech, and Bristol Myers Squibb.”

“FDA will share CDER’s most recent assessment of clinical trial diversity and discuss efforts to advance diverse participation in clinical trials including relevant FDA guidance and regulations.”

“All of Us Research Program Chief Engagement Officer Dr. Dara Richardson-Heron talks to community representatives about why people of different backgrounds should take part in health research. Representatives from Tuskegee University, PRIDEnet, Cherokee Health Systems, and Delta Research and Educational Foundation discuss the importance of diverse communities joining All of Us and the impact they can have to improve care and treatment for their communities.”

“IMPACT for Lupus is a grant awarded to the LFA by the Office of Minority Health. The goal of IMPACT for Lupus is to develop and test an innovative education model, within faith-based communities to raise awareness of lupus clinical trials among African Americans impacted by lupus.”